Answers are grounded in this paper and cite their sources.
Gray matter neuronal morphology is relevant to psychiatric diseases and pharmacotherapies. For instance, ketamine rapidly induces dendritic remodeling and spinogenesis which are required for its therapeutic effects in psychiatric disorders. A noninvasive biomarker of this phenomenon could aid in treatment response monitoring, patient stratification, or drug development. In principle, diffusion magnetic resonance imaging (dMRI) is sensitive to microstructure and could provide the desired approach. Here, we used three multishell dMRI-based models (diffusion tensor, neurite orientation dispersion and density, and diffusion kurtosis) in vivo to interrogate ketamine-induced microstructural changes in wild type mice and in the SAPAP3 knockout mouse model of compulsive behavior. Although histological analyses confirmed ketamine-induced increases in cortical synapse markers, we observed no corresponding changes in dMRI metrics. In Monte Carlo simulations of diffusion in scenes solely containing realistic dendrites, dMRI was sensitive to small morphological changes across gradient amplitudes only in noiseless conditions. In contrast, the same dMRI acquisitions resolved baseline microstructural differences between sexes and between SAPAP3 knockout and wild type mice, supporting the sensitivity of the method as implemented. Our findings suggest that the in vivo dMRI acquisition and modeling approaches used here lack sensitivity to detect the subtle dendritic morphology changes induced by ketamine.
No takes yet. Share an insight, caveat, or question.
Ewbank et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: